Figures
Abstract
Objective
Despite the implementation of the WHO Framework Convention on Tobacco Control (FCTC) program in Iran, the regulation of second-hand smoke (SHS) exposure—an often-overlooked hazard—, still requires improvement. We employed a multi-center case-control study to investigate the association between exposure to secondhand smoke (SHS) from various tobacco products (cigarettes, water-pipes, pipes, and chopogh), opium use, and the risk of lung cancer.
Method
We included 627 lung cancer cases and 3477 controls. Exposure to SHS tobacco and SHS opium was collected through a questionnaire. We used mixed-model logistic regressions to estimate odds ratios (ORs) and 95% confidence intervals (CI).
Result
Among the overall population exposed to second-hand tobacco smoke (SHTS), the odds ratio (OR) compared to those never exposed was 1.35 (95% CI: 1.08–1.71). Never smokers who were ever exposed to second-hand tobacco smoke (SHTS) had 1.69-fold risk of lung cancer compared to those who were never exposed (95% CI: 1.13–2.52). Exposure to SHTS between 2–3 per day (OR = 2.27, 95% CI: 1.13–4.53) and more than three hours per day (OR = 2.29, 95% CI: 1.20–4.37) can increase the risk of lung cancer compared with the no exposure group (P-trend <0.01). We did not observe any association between exposure to second-hand opium smoke (SHOS) and the risk of lung cancer, either in the overall population or among never-smokers.
Conclusion
Our study estimates the impact of second-hand tobacco smoke (SHTS) on lung cancer risk in both the overall population and never-smokers. Additional studies are required to evaluate the association between exposure to second-hand smoke from opium and other type of tobacco, including water-pipe and the risk of lung cancer.
Citation: Lotfi F, Rashidian H, Hadji M, Mohebbi E, Marzban M, Naghibzadeh-Tahami A, et al. (2024) Exposure to second-hand smoke and risk of lung cancer among Iranian population: A multicenter case-control study. PLoS ONE 19(7): e0306517. https://doi.org/10.1371/journal.pone.0306517
Editor: Hadi Ghasemi, Shahid Beheshti University of Medical Sciences School of Dentistry, ISLAMIC REPUBLIC OF IRAN
Received: June 29, 2022; Accepted: June 17, 2024; Published: July 10, 2024
Copyright: © 2024 Lotfi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: ALL SHS dataset are available from the kaggle database.https://www.kaggle.com/datasets/fereshtelotfi/secondhandsmoke.
Funding: The IROPICAN study was funded by the National Institute for Medical Research Development (NIMAD), Iran (grant number: 940045).
Competing interests: The authors have declared that no competing interests exist.
Introduction
Tobacco smoking is indisputably known as a risk factor for lung cancer. Studies have demonstrated lung cancer has the highest proportion of smoking-attributable cases (about 80%) [1–3]. While tobacco smoking is considered a leading cause of lung cancer, 10–15% of lung cancer cases occurred among people who never smoked [4]. Initially, there was a lack of available information regarding the descriptive epidemiology of lung cancer among never smokers. Evidence about this gap beyond the air pollution and occupational risk factors such as radon and asbestos remain unrecognized until the 1980s [5]. Thereafter several epidemiological studies have demonstrated the role of passive smoking or second-hand smoke (SHS) as a risk factor for adverse health outcomes, including respiratory effects in both children and adults, coronary heart disease and, cancer [6–10].
Second-hand tobacco smoke (SHTS) encompasses “mainstream smoke” exhaled by a smoker after inhaling cigarette smoke, and “sidestream smoke” derived from the tip of a cigarette, cigar, or smoking pipe [11]. Given that sidestream smoke is generated at a lower temperature from incomplete combustion, it comprises carcinogens with thicker density compared to mainstream smoke [12]. In general, it is estimated that there are more than 60 carcinogens or compounds with strong evidence of carcinogenicity in cigarette smoke and most of them are present in sidestream too. Many of these compounds are classified in groups 1 and 2A (carcinogenic and probably carcinogenic to humans) by the International Agency for Research on Cancer (IARC) [13].
Epidemiological findings on passive smoking indicated an association between SHTS and the risk of developing lung cancer [14–17]. Although, this association does not appear to receive much attention in the low- and middle-income countries [18]. In Eastern Mediterranean Region (EMRO) countries—where tobacco smoking is less common among women due to stigma and traditional cultural constraints—lung cancer is among the top 10 common cancer types in women [19]. In this region, 32% of women, a considerably higher percentage compared to the 22% of men, are exposed to second-hand smoke. Given that these women represent only 25% of the labor force, it is likely that a substantial amount of exposure occurs within their homes [20]. Additionally, it appears that pro-health policies related to waterpipe smoking in this region have lagged behind those for cigarette. The widespread misconception that water pipes are less harmful compared to other types of tobacco has led to water pipe smoking becoming the preferred choice of tobacco use in some of our provinces. The available information on waterpipe smoking in these regions raises concerns, particularly among young people. Consequently, measuring secondhand smoke exposure for this specific type of tobacco is essential [21–25].
In Southeast and East Asia, the proportion of lung cancer cases among never-smokers is notably higher than in other regions, ranging from 30% to 50% [26]. Given the significant prevalence of opium use in this region [27], it is plausible that exposure to second-hand opium smoke (SHOS) may contribute to this variation. Despite the widespread use of opium in countries such as Afghanistan and Iran, the impact of second-hand opium smoke (SHOS) on the risk of lung cancer has not been considered [28–30].
We aimed to use the data from a large multicenter case-control study in Iran and assess the association between exposure to second-hand opium smoke (Tariak) and second-hand tobacco, including cigarettes and waterpipes, pipe and chopogh, and the risk of lung cancer.
Method
Study population
We used the Iranian Study of Opium and Cancer (IROPICAN) data, a large multicenter case-control study conducted in 10 provinces of Iran from 2016 to 2020, that investigates the association between opium use and the risk of lung, colorectal, bladder, and head and neck cancers. We recruited 627 pathologically confirmed cases of the trachea (International Classification of Diseases for oncology third edition (ICD-O-3): C33) and bronchus and lung (C34) and 3477 healthy hospital visitor controls. Controls were frequently matched with the cases of several studied cancer types combined by sex, age (10-year intervals) and place of residence (capital city of the province/other) [31].
Exposure measurement
Details about questionnaire content are provided elsewhere [32]. In brief, we collected data on opium, cigarette and water pipe use, status including second-hand smoking and several confounding factors. We collected data about the ever exposure to second-hand tobacco including cigarettes, water-pipe, pipe and chopogh (a special pipe) and second-hand opium separately. Those who had daily exposure to SHTS during their lifetime were considered as ever exposed persons. A regular user was defined as a person who used the substances including cigarettes, waterpipe or opium at least once a week for six months. Those smokers not meeting the criteria for regular classification were designated as irregular smokers. The cumulative count of opium use was defined as the frequency of opium use multiplied by the duration of use. Cumulative cigarette smoking (pack-year) was calculated by multiplying the number of packs smoked in a day by the smoking duration (year). Cumulative water pipe smoking (head-year) was assessed by multiplying the number of heads used a day by smoking duration (year).
Additionally, detailed information about the number of daily hours and duration of exposure (month) to SHTS and SHOS was collected for ever exposed participants.
We used principal component analysis to determine the socioeconomic status of the participants [33]. Several components were used to evaluation of socioeconomic status which was mentioned elsewhere [32]. The response rates for cases and controls were 97% and 89%, respectively.
Statistical analysis
We first performed the analyses on the entire case-control data set. In addition, to eliminate the confounding effect of active smoking we repeated the analyses among never smokers of any product (i.e., cigarette, water pipe and opium). Participants who were exposed to SHTS daily were considered as ever exposed. In order to adjust for the clustering effect of study centers, we used mixed model regression analyses to obtain odds ratios (ORs) with 95% confidence interval (CI) for the association between exposure to second-hand smoke and the risk of lung cancer. We adjusted for age (5 categories), gender, place of residence (capital city of the province /others) socioeconomic status (low/high), cigarette (pack-year), opium (frequency-year) and water pipe (head- year) use as potential confounders in all models. In order to investigate dose-response relationship between exposure to SHTS and lung cancer risk, we used both daily hours and duration of exposure (month) variables. We categorized users into three categories according to the 50th and 75th centile in the controls for hours and duration of exposure variable. We used STATA software for statistical analyses (Ver. 14.0, Stata Corp, College Station, Texas). The study was approved by the Ethics Committee of the National Institute of Medical Research Development (NIMAD) (Code: IR.NIMAD.REC.1394.027).
Result
A total of 627 lung cancer cases with a mean age of 55.5 years and 3477 controls with a mean age of about 53 years were included in the study. The majority of cases and controls was men and older than 50 years old (Table 1). Although the overall proportion of women in the never-smokers group was higher compared to the total population. There was a significant association between exposure to SHTS and the risk of lung cancer in the overall population (OR = 1.35, 95% CI: 1.08–1.71) (Table 2). Also, among individuals who never smoked any product (i.e., cigarette, waterpipe, pipe, chopogh and opium), those who were ever exposed to second-hand tobacco smoke had a higher risk of lung cancer compared to the group that was never exposed (OR = 1.69, 95% CI: 1.13–2.52).
We found a positive association between daily hours of Second-hand tobacco smoke (SHTS) and risk of lung cancer among never smokers (P values for trend <0.01). Exposure to SHTS between two and three hours per day increased the risk of lung cancer compared to never exposed group (OR = 2.27, 95%CI: 1.13–4.53). The result was similar for the category of more than three hours of per day exposure to SHTS (OR = 2.29, %CI: 1.20–4.37). No association was found between the duration of exposure to SHTS and the risk of lung cancer. Also, we did not observe any association between lung cancer risk and exposure to second-hand opium smoke (SHOS) neither in the overall population (OR = 1.17, 95%CI: 0.66–2.07) nor among never smokers (OR = 1.00,95% CI:0.23–4.33). Likewise, examination of the joint effect didn’t show the interaction between regular smoking and exposure to SHTS (Result not shown in the Tables). Additionally, it was identified exposure to SHTS increased the risk of lung cancer among men (OR = 2.03, %CI: 1.04–3.97) and among individuals aged 60 or above (OR = 2.20, %CI: 1.25–3.87). No association was found between SHOS in term of age and gender distribution (Table 3).
Discussion
We studied exposure to second-hand tobacco (cigarettes, water-pipe, pipe and chopogh) and second-hand opium smoke in a multi-center case control study on lung cancer in Iran. We observed increased risk of lung cancer in relation to SHTS overall and among never smoker group. Additionally, we found exposure-response trend for the number of hours per day of SHTS exposure and the risk of lung cancer in the never-smoker group. Our study revealed an increasing risk of lung cancer among men and those of advanced age who have been exposed to secondhand tobacco smoke (SHTS). However, there was no association between exposed to second hand opium and risk of lung cancer.
Our observations are in accordance with several lines of evidence that confirmed that exposure to SHTS increases the risk of lung cancer. According to studies, the risk of lung cancer can increase by around 25% in people exposed to second-hand smoke [19]. Results from the international lung cancer consortium (ILCCO) in 2014 one of the largest second-hand smoke studies, the meta OR from eighteen case-control studies comparing ever vs. never exposed to SHS was significantly elevated (OR = 1.34, 95% CI: 1.24–1.45). The risk of small cell incidence was more than 3-fold [14]. Brennan examined SHS exposure in adulthood and the risk of lung cancer among never smokers in 2004. The result of this study showed a positive association between long-term exposure to SHTS and the risk of lung cancer among never smokers (OR = 1.32, 95% CI: 1.04–1.66) [15].
In recent years, anti-smoking programs have been developed in high Human Development Index (HDI) countries and the tobacco industry targeted low and middle-income countries to sell their products. In addition, the popularity of some types of tobacco like waterpipe in the certain region like the Eastern Mediterranean Region (EMRO) has raised concern about those who don’t smoke but are passively exposed to smoking in these areas. In some Middle East countries, women do not smoke tobacco due to social and cultural norms. However, women and children are affected groups by second-hand tobacco smoke at home and workplaces [34, 35].
The dose-response relationship of SHTS and risk of lung cancer are compatible with other studies [14, 15, 36]. We also did not observe associations between the duration of secondhand smoke exposure and the risk of lung cancer. This issue possibly stems from the focus on the duration of consumption of tobacco and opium compared to the duration of exposure to second-hand smoke of these products in this study.
Exposure to second-hand opium smoke has greatly been ignored by countries with traditionally opium use like Iran, Afghanistan, and Pakistan. Test of air, surface and hair samples taken from the family of opium users by International Narcotics and Law Enforcement Affairs (INL) in Afghanistan showed that second-hand smoke of opium and even third-hand smoke could pose a major concern for children, particularly regarding their brain development but unfortunately, they did not evaluate the carcinogenicity of SHOS on Afghan population [30]. In our study, the sensitivity surrounding opium consumption, due to its illegality and people’s unwillingness to disclose information about their drug use, may explain why we didn’t observe any effects of SHOS.
We tested the interaction of SHTS exposure with active smoking and it was not significant However, the results from some studies on second-hand smoking suggest that the joint effects of active and passive smoking on lung cancer are consistent with a multiplicative model [14].
The strengths of this study include recruitment of a large sample with high response rate and recruitment of cases and controls from different provinces of Iran. Moreover, using hospital visitor controls which were shown more suitable option for this study as well as well-trained interviewers are another advantage of IROPICAN study [37]. However, this study had some limitations. Given that the primary focus of the IROPICAN study was on opium use, the assessment of exposure to second-hand tobacco smoke (SHTS) and second-hand opium smoke (SHOS) was considered of lower priority. As a result, the measurement of second-hand smoke exposure was not conducted in the most precise manner due to the inadequacy of the questions. Also, studies with a concentration on the assessment of various SHS aspects including duration of exposure at home, work, or in public places can measure exposure rate more precisely. Given the nature of our data collection procedure, recall bias cannot be ruled out. It is expected the cases recall their exposure more than control group. Given these assumptions, our result would probably overestimate the association. Another limitation in the present study was the low sample size of never smoker lung cancer cases, therefore we could not assess the association by lung cancer histology. It should be acknowledged that some individuals categorized as “never exposed” in the model may have experienced occasional exposure, which has the potential to result in an underestimation of the impact of secondhand smoke (SHS) exposure on lung cancer. Additionally, the limited sample size in this subgroup, may have posed a challenge in identifying any association between second-hand opium exposure and age or gender distribution.
Although consumption of opium is considerably high in Iran, we could not find any association between lung cancer and second-hand opium use. First, opium users also usually smoke tobacco and evaluation of the pure effect of opium smoke is complicated. On the other hand, Illegalizing and stigmatizing opium use are important obstacles to collecting data from users or passively exposed groups. Though, designing a larger study and using a comprehensive questionnaire along with biomarker validation is required for a full assessment of this association.
In conclusion, the objective of this investigation was to examine the association of secondhand smoke (SHS) of tobacco (cigarettes, water-pipe, pipe and chopogh) as well as second hand opium on individuals who have never smoked. Our findings indicate that SHTS increases the risk of lung cancer among the Iranian population. However, it is important to note that our results might underestimate the true risk of second-hand smoke on lung cancer. Further studies are required to verify the association between second-hand smoking and the risk of lung and other tobacco-related cancers in the Iranian population, particularly among women. Additionally, it’s essential to design a questionnaire to measure second-hand opium smoking in this hotspot region. It is also important to assess exposure to waterpipe smoking, a re-emerging virulent strain in the tobacco epidemic.
References
- 1. Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA: a cancer journal for clinicians. 2018;68(1):31–54. pmid:29160902
- 2. Grundy A, Poirier AE, Khandwala F, Grevers X, Friedenreich CM, Brenner DR. Cancer incidence attributable to lifestyle and environmental factors in Alberta in 2012: summary of results. Canadian Medical Association Open Access Journal. 2017;5(3):E540–E5. pmid:28687643
- 3. Wang N, Mengersen K, Tong S, Kimlin M, Zhou M, Hu W. Global, regional, and national burden of lung cancer and its attributable risk factors, 1990 to 2017. Cancer. 2020;126(18):4220–34. pmid:32648980
- 4. Samet JM, Avila-Tang E, Boffetta P, Hannan LM, Olivo-Marston S, Thun MJ, et al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clinical Cancer Research. 2009;15(18):5626–45. pmid:19755391
- 5. Oberg M, Jaakkola M, Prüss-Üstün A, Peruga A, Woodward A, Organization WH. Global estimate of the burden of disease from second-hand smoke. 2010.
- 6. Dockery DW, Trichopoulos D. Risk of lung cancer from environmental exposures to tobacco smoke. Cancer Causes & Control. 1997;8(3):333–45. pmid:9498897
- 7. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. Bmj. 1997;315(7114):980–8. pmid:9365295
- 8. Boffetta P, Agudo A, Ahrens W, Benhamou E, Benhamou S, Darby SC, et al. Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. JNCI: Journal of the National Cancer Institute. 1998;90(19):1440–50. pmid:9776409
- 9. Zhong L, Goldberg MS, Parent M-É, Hanley JA. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung cancer. 2000;27(1):3–18. pmid:10672779
- 10.
General USPHSOotS. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General: US Department of Health and Human Services, Public Health Service, Office of …; 2006.
- 11. Nelson E. The miseries of passive smoiong. Human & experimental toxicology. 2001;20(2):61–83.
- 12. LEE CK BROWN BG, REED EA, COGGINS CRE, DOOLITTLE DJ, HAYES AW. Ninety-Day Inhalation Study in Rats, Using Aged and Diluted Sidestream Smoke from a Reference Cigarette: DNA Adducts and Alveolar Macrophage Cytogenetics. Toxicological Sciences. 1993;20(4):393–401.
- 13. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003;3(10):733–44. Epub 2003/10/23. pmid:14570033.
- 14. Kim CH, Lee YCA, Hung RJ, McNallan SR, Cote ML, Lim WY, et al. Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). International journal of cancer. 2014;135(8):1918–30. pmid:24615328
- 15. Brennan P, Buffler PA, Reynolds P, Wu AH, Wichmann HE, Agudo A, et al. Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: a pooled analysis of two large studies. International journal of cancer. 2004;109(1):125–31. pmid:14735478
- 16. Asomaning K, Miller DP, Liu G, Wain JC, Lynch TJ, Su L, et al. Second hand smoke, age of exposure and lung cancer risk. Lung cancer. 2008;61(1):13–20. pmid:18191495
- 17. Li M, Liu X, Zhang L. The relationship of indoor coal use and environmental tobacco smoke exposure with lung cancer in China: A meta-analysis. J Cancer Res Ther. 2018;14(Supplement):S7–s13. Epub 2018/03/27. pmid:29578143.
- 18. Organization WH. Exposure to second-hand smoke in selected public places in the Eastern Mediterranean Region: report of a pilot study. 2012.
- 19.
WHO G. Iran, Islamic Republic of Iran 2020.
- 20. Öberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. The lancet. 2011;377(9760):139–46. pmid:21112082
- 21. Nemati S, Rafei A, Freedman ND, Fotouhi A, Asgary F, Zendehdel K. Cigarette and water-pipe use in Iran: geographical distribution and time trends among the adult population; a pooled analysis of national STEPS surveys, 2006–2009. Archives of Iranian medicine. 2017;20(5):295–301. pmid:28510465
- 22. Abdollahpour I, Mansournia MA, Salimi Y, Nedjat S. Lifetime prevalence and correlates of smoking behavior in Iranian adults’ population; a cross-sectional study. BMC public health. 2019;19(1):1–11.
- 23. Ansari-Moghaddam A, Rakhshani F, Shahraki-Sanavi F, Mohammadi M, Miri-Bonjar M, Bakhshani N-M. Prevalence and patterns of tobacco, alcohol, and drug use among Iranian adolescents: A meta-analysis of 58 studies. Children and Youth Services Review. 2016;60:68–79.
- 24. Maziak W, Ward KD, Soweid RA, Eissenberg T. Tobacco smoking using a waterpipe: a re-emerging strain in a global epidemic. Tobacco control. 2004;13(4):327–33. pmid:15564614
- 25. Warren CW, Lea V, Lee J, Jones NR, Asma S, McKenna M. Change in tobacco use among 13–15 year olds between 1999 and 2008: findings from the Global Youth Tobacco Survey. Global health promotion. 2009;16(2_suppl):38–90. pmid:19770234
- 26. Zhou F, Zhou C. Lung cancer in never smokers—the East Asian experience. Translational lung cancer research. 2018;7(4):450. pmid:30225210
- 27. Devaney ML, Reid G, Baldwin S. Prevalence of illicit drug use in Asia and the Pacific. Drug Alcohol Rev. 2007;26(1):97–102. Epub 2007/03/17. pmid:17364842.
- 28. Rostam-Abadi Y, Gholami J, Jobehdar MM, Ardeshir M, Aghaei AM, Olamazadeh S, et al. Drug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review. The Lancet Psychiatry. 2023. pmid:36848914
- 29. Sheikh M, Shakeri R, Poustchi H, Pourshams A, Etemadi A, Islami F, et al. Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study. The Lancet Global Health. 2020;8(5):e649–e60. pmid:32353313
- 30.
Goldberger BA, Martin DM, Gold M. Opium smoke: The study of second-and third-hand exposure in women and children of Afghanistan. Department of State, Bureau for International Narcotics and Law Enforcement Affairs. 2010.
- 31. Hadji M, Rashidian H, Marzban M, Gholipour M, Naghibzadeh-Tahami A, Mohebbi E, et al. The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings. Arch Iran Med. 2021;24(3):167–76. pmid:33878874
- 32. Hadji M, Rashidian H, Marzban M, Gholipour M, Naghibzadeh-Tahami A, Mohebbi E, et al. The Iranian Study of Opium and Cancer (IROPICAN): Rationale, design, and initial findings. 2021.
- 33. Marzban M, Hadji M, Gholipour M, Rashidian H, Rezaianzadeh A, Hasanzadeh J, et al. Association of socioeconomic status with consumption of cigarettes, illicit drugs, and alcohol. Journal of ethnicity in substance abuse. 2019;18(2):309–18. pmid:28820664
- 34. Bloch M, Tong VT, Novotny TE, England LJ, Dietz PM, Kim SY, et al. Tobacco use and secondhand smoke exposure among pregnant women in low‐and middle‐income countries: a call to action. Acta Obstetricia et Gynecologica Scandinavica. 2010;89(4):418–22. pmid:20367426
- 35. Ni X, Xu N, Wang Q. Meta-analysis and systematic review in environmental tobacco smoke risk of female lung cancer by research type. International journal of environmental research and public health. 2018;15(7):1348. pmid:29954105
- 36. Robinson RJ. Carcinogen specific dosimetry model for passive smokers of various ages. Science of the total environment. 2005;338(3):201–12. pmid:15713329
- 37. Rashidian H, Hadji M, Marzban M, Gholipour M, Rahimi-Movaghar A, Kamangar F, et al. Sensitivity of self-reported opioid use in case-control studies: Healthy individuals versus hospitalized patients. PloS one. 2017;12(8):e0183017. pmid:28854228